Evaluation of Effectiveness of Two Different Doses of Mivacurium in Modified Rapid Sequence Intubation for Emergency Surgery ,Prospective Randomized Double Blind Study
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Mivacurium can be considered as an optimal choice for muscle relaxation in short duration surgeries, as butyrylcholinesterase can rapidly and reliably degrade this benzylisoquinoline muscle relaxant in vivo. However the histamine release related to a rapid high-dose injection, unsatisfactory intubation conditions and unexpected delay in recovery in patients may be encountered with butyrylcholinesterase deficiency
Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 60
Healthy Volunteers: f
View:
• 20-60 year old patients.
• American society of anaesthesia (ASA) 1 and 2.
• Emergency surgery.
Locations
Other Locations
Egypt
Al Azhar University
RECRUITING
Cairo
Contact Information
Primary
ismail m ahmed, professor
ismailabdelgawad.623@azhar.edu.eg
00201117310053
Time Frame
Start Date: 2023-09-01
Estimated Completion Date: 2024-01
Participants
Target number of participants: 100
Treatments
Active_comparator: Miva 3
Mivacurium chloride (Mivacron®) 0.3 mg/kg 3 times effective dose (ED) 95 iv during induction recording intubation condition during rapid sequence intubation within 90 sc monitoring hemodynamic changes during intubation ,time to recover to T1
Active_comparator: Miva 4
Mivacurium chloride (Mivacron®) 0.4 mg/kg 4 times effective dose (ED) 95 iv during induction~recording intubation condition during rapid sequence intubation within 90 sc monitoring hemodynamic changes during intubation,time to recover to T1
Related Therapeutic Areas
Sponsors
Leads: Al-Azhar University